Author

K. V. Pathak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1

Frequent Co-Authors

P. Pirrotte· 2 shared A. Cheng· 1 shared A. N. Karnezis· 1 shared B. E. Weissman· 1 shared B. Tessier-Cloutier· 1 shared C. B. Gilks· 1 shared C. Chow· 1 shared C. K. Hu· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

P. Pirrotte

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular profiling of innate immune response mechanisms in ventilator-associated pneumonia

K. V. PATHAK, M. I. McGilvrey, C. K. Hu, K. Garcia-Mansfield, K. Lewandoski, Z. Eftekhari, Y.-C. Yuan, F. Zenhausern, E. Menashi, P. Pirrotte

This study profiles proteome and metabolome changes in endotracheal aspirates (ETA) and bronchoalveolar lavage (BAL) from VAP patients to identify early host-pathogen interactions.

bioRxiv · Jan 8, 2020Immunology

Arginine depletion through ADI-PEG20 to treat argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type

J. X. Ji, D. R. Cochrane, B. Tessier-Cloutier, S. Chen, G. Ho, K. V. Pathak, I. Alcazar, D. Farnell, S. Leung, A. Cheng, C. Chow, S. Colborne, G. Luca Negri, F. Kommoss, A. N. Karnezis, , D. G. Huntsman

This paper identifies ASS1 deficiency in rare ovarian cancers and shows that ADI-PEG20 inhibits tumor growth in ASS1-deficient models.

bioRxiv · Nov 17, 2019 · PreprintCancer Biology